ARTICLE | Clinical News
Fountain Pharmaceuticals Inc. regulatory update
January 17, 1994 8:00 AM UTC
FPHI (Largo, Fla.) received U.S. Patent No. 5,269,979 covering its LyphaZome technology, which is central to the company’s encapsulated drug delivery systems. The patent covers a method of manufacturi...